Dana McGlothlin

Summary

Affiliation: University of California
Country: USA

Publications

  1. ncbi Anesthesia and pulmonary hypertension
    Dana McGlothlin
    Division of Cardiology, University of California San Francisco, CA, USA
    Prog Cardiovasc Dis 55:199-217. 2012
  2. ncbi Classification of pulmonary hypertension
    Dana McGlothlin
    Division of Cardiology, UCSF Medical Center, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0124, USA
    Heart Fail Clin 8:301-17. 2012
  3. ncbi Transplantation in adults with congenital heart disease
    Dana McGlothlin
    Division of Cardiology, Heart Failure, Heart Transplantation, and Pulmonary Hypertension Programs, University of California, San Francisco, CA, USA
    Prog Cardiovasc Dis 53:312-23. 2011
  4. ncbi Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients
    Nicolas Amabile
    Department of Medicine, Division of Cardiology, University of California at San Francisco, San Francisco, California, USA
    J Heart Lung Transplant 28:1081-6. 2009
  5. ncbi Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival
    Rebecca Cogswell
    Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA
    J Heart Lung Transplant 31:1165-70. 2012
  6. ncbi Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension
    Rebecca Cogswell
    Division of Cardiology, University of California, San Francisco, San Francisco, CA 94117, USA
    J Heart Lung Transplant 32:293-8. 2013
  7. ncbi Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database
    Kiran K Khush
    Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, USA
    Am Heart J 157:1026-34. 2009
  8. ncbi Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
    Nicolas Amabile
    Division of Cardiology, Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0103, USA
    Am J Respir Crit Care Med 177:1268-75. 2008
  9. ncbi Analytic reviews: cardiogenic shock with preserved systolic function: a reminder
    Kanu Chatterjee
    Division of Cardiology, Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    J Intensive Care Med 23:355-66. 2008
  10. ncbi The clinical pharmacology of intranasal l-methamphetamine
    John E Mendelson
    Addiction Pharmacology Research Laboratory, The California Pacific Medical Center Research Institute, St Luke s Hospital, 7th Floor, 3555 Cesar Chavez Street, San Francisco, CA 94110, USA
    BMC Clin Pharmacol 8:4. 2008

Detail Information

Publications10

  1. ncbi Anesthesia and pulmonary hypertension
    Dana McGlothlin
    Division of Cardiology, University of California San Francisco, CA, USA
    Prog Cardiovasc Dis 55:199-217. 2012
    ..This article will cover each of these aspects with particular focus on the anesthetic approach for non-cardiothoracic surgeries...
  2. ncbi Classification of pulmonary hypertension
    Dana McGlothlin
    Division of Cardiology, UCSF Medical Center, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0124, USA
    Heart Fail Clin 8:301-17. 2012
    ..As our understanding of the different pathologic mechanisms that underlie the syndrome of PH evolves, so too will the classification and treatment of PH...
  3. ncbi Transplantation in adults with congenital heart disease
    Dana McGlothlin
    Division of Cardiology, Heart Failure, Heart Transplantation, and Pulmonary Hypertension Programs, University of California, San Francisco, CA, USA
    Prog Cardiovasc Dis 53:312-23. 2011
    ..However, those who survive of the first posttransplant year enjoy an excellent long-term prognosis...
  4. ncbi Increased CD62e(+) endothelial microparticle levels predict poor outcome in pulmonary hypertension patients
    Nicolas Amabile
    Department of Medicine, Division of Cardiology, University of California at San Francisco, San Francisco, California, USA
    J Heart Lung Transplant 28:1081-6. 2009
    ..We hypothesized that the levels of circulating EMPs and LMPs could predict outcome in these patients...
  5. ncbi Validation of the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL) pulmonary hypertension prediction model in a unique population and utility in the prediction of long-term survival
    Rebecca Cogswell
    Division of Cardiology, University of California, San Francisco, San Francisco, CA, USA
    J Heart Lung Transplant 31:1165-70. 2012
    ..Multivariate prediction models need to be evaluated in cohorts distinct from the derivation set to determine external validity. In addition, limited data exist on the utility of this model in the prediction of long-term survival...
  6. ncbi Performance of the REVEAL model in WHO Group 2 to 5 pulmonary hypertension: application beyond pulmonary arterial hypertension
    Rebecca Cogswell
    Division of Cardiology, University of California, San Francisco, San Francisco, CA 94117, USA
    J Heart Lung Transplant 32:293-8. 2013
    ..The REVEAL score was designed to predict 1-year survival in patients with pulmonary arterial hypertension (PAH) only. It is unknown whether this model is applicable to a more general population of PH patients...
  7. ncbi Effect of pulmonary hypertension on clinical outcomes in advanced heart failure: analysis of the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) database
    Kiran K Khush
    Division of Cardiovascular Medicine, Department of Medicine, Stanford University, Stanford, CA, USA
    Am Heart J 157:1026-34. 2009
    ....
  8. ncbi Circulating endothelial microparticle levels predict hemodynamic severity of pulmonary hypertension
    Nicolas Amabile
    Division of Cardiology, Department of Medicine, University of California, San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143 0103, USA
    Am J Respir Crit Care Med 177:1268-75. 2008
    ..Endothelial MPs are a biological marker of dysfunctional endothelium. Vascular remodeling and endothelial dysfunction are involved in pulmonary hypertension (PH)...
  9. ncbi Analytic reviews: cardiogenic shock with preserved systolic function: a reminder
    Kanu Chatterjee
    Division of Cardiology, Department of Medicine, University of California San Francisco, 505 Parnassus Avenue, San Francisco, CA 94143, USA
    J Intensive Care Med 23:355-66. 2008
    ..In this review, the important causes, pathophysiology, diagnosis, and therapies of patients with "cardiogenic shock with preserved ejection fraction'' are discussed...
  10. ncbi The clinical pharmacology of intranasal l-methamphetamine
    John E Mendelson
    Addiction Pharmacology Research Laboratory, The California Pacific Medical Center Research Institute, St Luke s Hospital, 7th Floor, 3555 Cesar Chavez Street, San Francisco, CA 94110, USA
    BMC Clin Pharmacol 8:4. 2008
    ..We studied the pharmacology of l-methamphetamine, the less abused isomer, when used as a nasal decongestant...